NO991227L - PTX-sensitive G-proteiner, deres fremstilling og bruk - Google Patents

PTX-sensitive G-proteiner, deres fremstilling og bruk

Info

Publication number
NO991227L
NO991227L NO991227A NO991227A NO991227L NO 991227 L NO991227 L NO 991227L NO 991227 A NO991227 A NO 991227A NO 991227 A NO991227 A NO 991227A NO 991227 L NO991227 L NO 991227L
Authority
NO
Norway
Prior art keywords
ptx
proteins
sensitive
preparation
subunit
Prior art date
Application number
NO991227A
Other languages
English (en)
Other versions
NO991227D0 (no
Inventor
Winfried Siffert
Original Assignee
Winfried Siffert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Winfried Siffert filed Critical Winfried Siffert
Publication of NO991227D0 publication Critical patent/NO991227D0/no
Publication of NO991227L publication Critical patent/NO991227L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)

Abstract

Beta-3-subenhet for et humant G-protein, bestående hovedsakelig av 6 WD-repeterende struktur.
NO991227A 1996-09-13 1999-03-12 PTX-sensitive G-proteiner, deres fremstilling og bruk NO991227L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19637518A DE19637518A1 (de) 1996-09-13 1996-09-13 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung
PCT/EP1997/004709 WO1998011212A1 (de) 1996-09-13 1997-08-29 Ptx-sensitive g-proteine, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
NO991227D0 NO991227D0 (no) 1999-03-12
NO991227L true NO991227L (no) 1999-03-12

Family

ID=7805651

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991227A NO991227L (no) 1996-09-13 1999-03-12 PTX-sensitive G-proteiner, deres fremstilling og bruk

Country Status (22)

Country Link
US (1) US6251853B1 (no)
EP (1) EP0931145A1 (no)
JP (1) JP2001501811A (no)
KR (1) KR20000036058A (no)
CN (1) CN1230222A (no)
AU (1) AU4619297A (no)
BG (1) BG103238A (no)
BR (1) BR9711475A (no)
CA (1) CA2265467A1 (no)
CZ (1) CZ73499A3 (no)
DE (1) DE19637518A1 (no)
EA (1) EA199900253A1 (no)
EE (1) EE9900092A (no)
HU (1) HUP9904110A3 (no)
IL (1) IL128746A0 (no)
IS (1) IS4987A (no)
NO (1) NO991227L (no)
PL (1) PL332417A1 (no)
SK (1) SK34099A3 (no)
TR (1) TR199900500T2 (no)
WO (1) WO1998011212A1 (no)
ZA (1) ZA978220B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen
AU3975799A (en) * 1998-05-11 1999-11-29 Axys Pharmaceuticals, Inc. (rhoh) genes and their uses
JP2002525051A (ja) * 1998-09-10 2002-08-13 ジフェルト，ビンフリート ヒトｇタンパク質のｇベータ３サブユニットのための遺伝子内の遺伝子変更
FR2803525B1 (fr) * 2000-01-06 2002-05-03 Sod Conseils Rech Applic Inhibiteur de la transduction des signaux des proteines g heterotrimeriques associe a un agent anti-hypertenseur dans le traitement de l'hypertension arterielle
EP1268852A1 (de) * 2000-02-03 2003-01-02 Winfried Siffert Verwendung einer genveränderung im gen für die beta-3-untereinheit des humanen g-proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587561A (en) 1995-07-28 1996-12-24 Budayr; Mahdi Stethoscope shield
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen

Also Published As

Publication number Publication date
BR9711475A (pt) 1999-08-24
IS4987A (is) 1999-02-26
JP2001501811A (ja) 2001-02-13
SK34099A3 (en) 2000-05-16
EE9900092A (et) 1999-10-15
US6251853B1 (en) 2001-06-26
TR199900500T2 (xx) 1999-06-21
ZA978220B (en) 1999-03-12
HUP9904110A3 (en) 2001-09-28
DE19637518A1 (de) 1998-04-09
NO991227D0 (no) 1999-03-12
KR20000036058A (ko) 2000-06-26
EA199900253A1 (ru) 1999-10-28
EP0931145A1 (de) 1999-07-28
IL128746A0 (en) 2000-01-31
AU4619297A (en) 1998-04-02
CZ73499A3 (cs) 1999-07-14
PL332417A1 (en) 1999-09-13
WO1998011212A1 (de) 1998-03-19
CA2265467A1 (en) 1998-03-19
HUP9904110A2 (en) 2000-07-28
CN1230222A (zh) 1999-09-29
BG103238A (bg) 2000-06-30

Similar Documents

Publication Publication Date Title
DK614289A (da) Konjugater af et membranprotein og et peptid, deres fremstilling og anvendelse
DK0832104T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
NO961160L (no) Cykliske forbindelser, deres fremstilling og anvendelse
DK374389D0 (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
DK388989D0 (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
DK435289A (da) Piperazindioner, deres fremstilling og anvendelse
NO991227L (no) PTX-sensitive G-proteiner, deres fremstilling og bruk
NO951418D0 (no) Peptidderivater, deres fremstilling og anvendelse som terapeutika
NO962477D0 (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
DK60893D0 (da) Piperidinderivater, deres fremstilling og anvendelse
DK698188A (da) Peptider, deres fremstilling og anvendelse
DK199989A (da) Angucyclinoner fra streptomyceter, deres fremstilling og anvendelse
NO973230D0 (no) Nye peptider, deres fremstilling og anvendelse
DK51789D0 (da) Aminosyreamider, deres fremstilling og anvendelse
DK225089D0 (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
DK162087D0 (da) Piperidinforbindelser, deres fremstilling og anvendelse
NO972822D0 (no) Fluoralkylglycosiduronsyrer og tilsvarende 6(3)-lactoner, deres fremstilling og anvendelse
DK185489D0 (da) Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse
DK592389A (da) Penemderivater, deres fremstilling og anvendelse
DK202089A (da) Angucyclinoner fra streptomyceter, deres fremstilling og anvendelse
DK224187A (da) Cycliske peptider, deres fremstilling og anvendelse
ATE366261T1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
AU7043301A (en) A novel polypeptide, a human protein 9 containing a fragment of p5cr specific sequence
DK573085D0 (da) N-(3-chlor-1,2,4-oxadiazol-5-yl)urinstoffer, deres fremstilling og anvendelse
DK455189A (da) 2,3,4,5-tetrahydro-1-benzoxepiner, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application